User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Oct 31 2014 15:50 IST RSS 2.0
 
1 to 20 of 9,604    
Education will be the single biggest transformative factor in catapulting India into the league of developed nations, says President 31.10.2014 Govt of india: PIB
A two day Conference of Directors of National Institutes of Technology convened by Shri Pranab Mukherjee, the President of India in his capacity as Visitor concluded yesterday (October 30, 2014) at Rashtrapati Bhavan.
Also found in: [+]
IPR thinktank to fast-track patent policy road map 31.10.2014 TOI: India Business
Official sources said that after the submission of the first draft in March next year, a Cabinet note will be prepared, adding that the first draft is expected to be submitted by the panel by November (next month).
Also found in: [+]
Roche-Cipla patent row mediation fails 31.10.2014 TOI: India Business
Efforts to end the long and bitter patent tussle between domestic pharma company Cipla and multinational Roche over a lung cancer drug have come to a naught, with the Delhi high court-appointed mediator submitting its “failure” report in the case.
Also found in: [+]
Cipla asks government to revoke Novartis' patent; launches its drug 30.10.2014 ET: Pharma
Cipla has launched low-cost generic version of Novartis's respiratory drug Indacaterol while asking government to revoke patents over the medicine.
Also found in: [+]
Lenovo closes US $2.91 billion Motorola acquisition from Google 30.10.2014 DNA: Mumbai
China's Lenovo Group Ltd announced today it has closed a US $2.91 billion acquisition of the Motorola handset unit from Google, strengthening it's foothold in the smartphone market.  IT’S OFFICIAL:  @Motorola  is now a Lenovo company. Warm welcome & #HelloMoto . Details:  http://t.co/G7hibbFAT1 pic.twitter.com/90JyDolZCB — Lenovo (@lenovo) October 30, 2014 Google first got its hands on the Motorola brand and its sleek phone design in 2012 for US $ 12.5 billion but has since struggled to halt Motorola's downward spiral within the ultra-competitive smartphone industry. Under the tenets of the new deal , Google will retain a significant portion of Motorola's patent portfolio, whereas Lenovo will gain Motorola Mobility  as a subsidiary, and Motorola will receive a licence to utilise its patents.  Report Sci/Tech DNA Webdesk Acquisition Motorola Lenovo google smartphone Thursday, 30 October 2014 - 4:51pmThursday, 30 October 2014 - ...
Also found in: [+]
Cipla asks government to revoke Novartis patents on respiratory drug 30.10.2014 Sify Finance
Also found in: [+]
Cipla asks government to cancel Novartis patents on respiratory drug 30.10.2014 ET: Pharma
Onbrez, chemically called indicaterol, is used to treat breathing problems associated with chronic obstructive pulmonary disease.
Also found in: [+]
Cipla asks government to revoke five patents held by Novartis 30.10.2014 ET: Pharma
Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez.
Also found in: [+]
Indian drugmakers asks US Trade Representative body to restore faith in new trade policy 30.10.2014 ET: Pharma
Indian Pharma Alliance, a grouping of top domestic drugmakers, in its latest submission has urged the USTR to consider submissions of many American firms across sectors.
Also found in: [+]
Ranbaxy Laboratories still has exclusive rights for Nexium generic: CEO Arun Sawhney 28.10.2014 ET: Pharma
Ranbaxy was first to seek approval from US FDA to sell a cheaper copy of Nexium, gaining exclusive rights to sell it for 6 months after patent expiry.
Also found in: [+]
India, China to command 70% of $20-bn global biosimilars market 28.10.2014 Sify Finance
India and China would together command around 70 per cent of the $20-billion global biosimilars market, supported by low-cost manufacturing, less expenditure incurred on research and development
Also found in: [+]
IIM-Calcutta girl gives 15 reasons to celebrate life 28.10.2014 TOI: Calcutta Times
An IIM-Calcutta alumna has compiled a book with real-life success stories of persons with disabilities who have soared above their limitations and become icons to emulate.
Also found in: [+]
Book Review: Because Life is a Gift 25.10.2014 DNA: Wide Angle
Book: Because Life is a Gift Publisher: Srishti Publishers & Distributors Pages: 208 Price: Rs 125 Disha is an unusual achiever. A graduate from Delhi College of Engineering and Indian Institute of Management (IIM) Kolkata, she balances a high pressure job in a travel organisation along with her writing and has authored two books in as many years. Her books are unusual too. She doesn't write just for herself (as many writers claim to), nor does she write for her readers (as the other half assert). Instead, she writes on topics that touch her, telling stories she believes must be told — and brought alive. "Because no one else writes about them," she says. Her first book, My Beloved's MBA Plans (Sristhti Publications), released to rave reviews last August. It was a rather interesting take on modern day relationships. Written in an interview format, it told the stories of 16 real life couples whom Disha interviewed while she was doing her MBA. Sacrifices, adjustments, unconventional choices, the tug between ...
Also found in: [+]
Subramanian till recently had opposed India on IPR 25.10.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global ...
Also found in: [+]
Govt sets up 6-member IPR think tank 25.10.2014 TOI: India Business
Taking into account India’s dismal performance in protecting intellectual property rights over drug and agricultural products, the Centre has formed a six-member ‘think tank’ to draft national IPR policy and suggest legal means to handle undue pressure exerted by other countries on this issue.
Also found in: [+]
DIPP sets up think tank to draft national Intellectual Property Rights policy 24.10.2014 ET: Policy
It will keep the government regularly informed about the developments taking place in IPR cases which have an impact upon India's IPR Policy, it said.
Also found in: [+]
40 years ago and now: How Ranbaxy moved out of family control 22.10.2014 Rediff: Business
Ranbaxy did its maiden public issue in 1973.
Also found in: [+]
Government may propose sub-groups on other contentious issues under ambit of IPR panel 22.10.2014 ET: Pharma
During PM Modi’s visit to the US, the two countries committed to set up an annual high-level IP working group as part of the trade policy forum.
Also found in: [+]
Natco Pharma's US partner gets FDA nod for wakefulness tablets 21.10.2014 ET: Pharma
Breckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.
Also found in: [+]
Pharma companies feel law change can weaken ability to provide low-cost drugs 21.10.2014 ET: Pharma
Indian drugmakers are also concerned about a shift in India’s position on IPR, which they say is being keenly watched by many developing countries.
Also found in: [+]
1 to 20 of 9,604